Breaking News, Financial News

Financial Report: GlaxoSmithKline 2Q

Pharmaceutical sales were $8.7 billion in the quarter (-11%). Seretide/Advair sales were flat at $1.9 billion.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline 2Q 2Q Revenues: $10.5 billion (-10%) 2Q Earnings: $2.3 billion (-12%) YTD Revenues: $20.3 billion (-12%) YTD Earnings: $3.9 billion (-25%) Comments: Pharmaceutical sales were $8.7 billion in the quarter (-11%). Seretide/Advair sales were flat at $1.9 billion. Valtrex sales were $590 million (+7%). Combivir sales were down 23% to $160 million. Epzicom/Kivexa sales were $202 million (-2%). Seroxat/Paxil sales were $215 million (-15%). Avodart sales were up 14% to $20...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters